Actively Recruiting

Phase 4
Age: 19Years +
All Genders
NCT06330038

Anesthesia and Non-small Cell Lung Cancer Recurrence

Led by Samsung Medical Center · Updated on 2026-04-20

5384

Participants Needed

1

Research Sites

229 weeks

Total Duration

On this page

Sponsors

S

Samsung Medical Center

Lead Sponsor

S

Seoul National University Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

There has been ongoing debate about the relationship between cancer recurrence and anesthetic management. Therefore, the investigators will test the hypothesis that the recurrence free survival (RFS) after curative resection of NSCLC is higher in patient who received total intravenous anesthesia (TIVA) than volatile anesthetics in this multi-center randomized trials.

CONDITIONS

Official Title

Anesthesia and Non-small Cell Lung Cancer Recurrence

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 19 years or older
  • American Society of Anesthesiologists physical status (ASA) I to III
  • Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2
  • Scheduled for lung resection surgery (segmentectomy, lobectomy, bilobectomy, pneumonectomy) with curative intent for NSCLC at clinical Tumor, Node, Metastasis (TNM) stage I to IIA
Not Eligible

You will not qualify if you...

  • Presence of distant metastasis or malignant tumor in other organs not in long-term remission
  • Severe neurological conditions
  • Severe liver disease classified as Child-Pugh C
  • Renal failure requiring renal replacement therapy
  • Anesthesia and/or surgery within the past year
  • Previous lung cancer surgery except diagnostic biopsies
  • Allergies or contraindications to study medications
  • Planned combined extrapulmonary surgical procedures
  • Surgery involving cardiopulmonary bypass or extracorporeal membrane oxygenation
  • Postoperative sedation
  • Pregnancy or breastfeeding
  • Patient refusal to participate

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Samsung Medical Center

Seoul, Seoul-teukbyeolsi, South Korea, 06351

Actively Recruiting

Loading map...

Research Team

J

Jeayoun Kim, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here